CA Patent

CA2680825C — Topical formulations having enhanced bioavailability

Assigned to BERG LLC · Expires 2013-10-29 · 13y expired

What this patent protects

The present disclosure provides compositions suitable for delivering lipophilic bioactive agents. The compositions may be utilized to treat numerous diseases and conditions that would benefit from the application of a lipophilic bioactive agent.

USPTO Abstract

The present disclosure provides compositions suitable for delivering lipophilic bioactive agents. The compositions may be utilized to treat numerous diseases and conditions that would benefit from the application of a lipophilic bioactive agent.

Drugs covered by this patent

Patent Metadata

Patent number
CA2680825C
Jurisdiction
CA
Classification
—
Expires
2013-10-29
Drug substance claim
No
Drug product claim
No
Assignee
BERG LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.